2019
DOI: 10.2147/ijn.s212907
|View full text |Cite
|
Sign up to set email alerts
|

<p>The Toxicity Of Metallic Nanoparticles On Liver: The Subcellular Damages, Mechanisms, And Outcomes</p>

Abstract: Metallic nanoparticles (MNPs) are new engineering materials with broad prospects for biomedical applications; thus, their biosafety has drawn great concern. The liver is the main detoxification organ of vertebrates. However, many issues concerning the interactions between MNPs and biological systems (cells and tissues) are unclear, particularly the toxic effects of MNPs on hepatocytes and other liver cells. Numerous researchers have shown that some MNPs can induce decreased cell survival rate, production of re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
105
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 153 publications
(106 citation statements)
references
References 114 publications
1
105
0
Order By: Relevance
“…The liver, one of the main internal organs of the body, is responsible for detoxification and plays an important role in metabolic pathways, such as protein synthesis and nutrient storage [ 52 ]. The liver is inflamed and damaged by oxidative stress, such as ROS.…”
Section: Discussionmentioning
confidence: 99%
“…The liver, one of the main internal organs of the body, is responsible for detoxification and plays an important role in metabolic pathways, such as protein synthesis and nutrient storage [ 52 ]. The liver is inflamed and damaged by oxidative stress, such as ROS.…”
Section: Discussionmentioning
confidence: 99%
“…The toxicity of metallic nanotherapeutics depends on its biodegradability, the chemical meltability nature, and surface adsorption capacity. In the case of metallic nanotherapeutics, a larger surface per unit mass can induce the higher adsorption of proteins, nutrients, and growth factors, affecting the toxicity of the agent (Yao et al, 2019 ). However, the surface modification of metallic nanotherapeutics with biocompatible moieties can avoid unnecessary accumulation in different organs and protein adsorption, thereby reducing toxicity and side effects.…”
Section: Biosafety Of Metallic Nanotherapeuticsmentioning
confidence: 99%
“…The toxicity of metallic nanoparticles for humans is still unknown, there are still many studies in vitro and the big problem is that its bioaccumulation occurs in tissues and organs ( Yao et al, 2019 ). With regard to immunogenicity, there are few studies in the literature relating the physical-chemical properties of metallic nanoparticles and their potential effects on the immune system in order to have a more precise understanding of activity structure, more studies are needed ( Engin and Hayes, 2018 ).…”
Section: Pharmaceutical Nanotechnologymentioning
confidence: 99%